Dr. Banov discusses his concerns and cautions regarding the flurry of over promises around psychedelics as potential treatments for a variety of mental health conditions including treatment resistant depression and anxiety.
Should You Believe in Science?
Strange question but more people are asking it in the last few years especially with confusion, misinformation, and politicization around COVID. Now, I’m no expert about COVID and how to safely avoid and treat it, although plenty of my non-healthcare professional friends and family ask me questions all the time. But what I am an expert in is in treating mood and anxiety disorders. Mostly what I treat are people that have either failed or are intolerant to traditional, approved medication therapies. But there are many other treatment options that may not have undergone the scrutiny of the Food and Drug Administration (FDA) or other government agency but there are controlled and well conducted studies showing they are effective and safe as well as a good deal of clinical experience with the treatments. Do we offer these options to our patients or not? What is our threshold as healthcare providers for non-FDA approved therapies?
As someone that has done clinical research for over two decades with new psychiatric medications, often studies use participants that are cherry picked in such a way that they do not represent the real world patients that we would use the treatment for. They are more designed to get the FDA to approve the treatment rather than tell us who would really do well and for whom it may be safe to use. And just because a treatment was shown in a clinical trial to be safe, there are many examples of medications taken off the market because unsafe side effects appeared later.
Where this issue has presented itself prominently in psychiatry is in the use of ketamine for mood and anxiety disorders. The drug has been around for over 40 years and has been shown to be safe in children, adults, and seniors as an anesthetic agent. There are many studies showing it is safe and effective for many psychiatric conditions. While these studies may not meet the standard for FDA drug approval, they may be more real world and generalizable for the patients we see every day who are desperate for treatment alternatives.
With the proliferation of access to information and more well informed consumers, it seems that our society is evolving in a way that people want the freedom of choice for healthcare alternatives. And are willing to take the risks-known and unknown. This is evident in the increasing legalization of medical cannabis and interest in psychedelics such as psilocybin, MDMA, and LSD.
I personally believe that we need some science. I haven't made a decision yet as to whether to advocate for medical cannabis or psychedelics for treatment of mental health disorders. But when it comes to ketamine, I’m a believer, even if the FDA hasn’t bought in yet. I have seen too many people’s lives changed for the better, too many people whose daily suicidal thoughts have disappeared, and too many smiles return to faces that haven’t smiled for many years. And while it doesn't work for everyone, for everything, and indefinitely, it works enough.
You Might Also Enjoy...
Dr. Banov discusses his concerns and cautions regarding the flurry of over promises around psychedelics as potential treatments for a variety of mental health conditions including treatment resistant depression and anxiety.
Ketamine has been shown to be a rapid and effective treatment for an acute depressive episode but what about its' effectiveness in preventing a depression relapse? Can and should ketamine be used as a maintenance depression therapy? Is ketamine a cure?
Psychiatry has evolved in the last decade to offering more interventional therapies for treatment resistant psychiatric conditions. We now have transcranial magnetic stimulation (TMS), ketamine, and Spravato. Which is best? Answer: Depends.
Dr. Banov discusses alternatives to treating depression without typical antidepressant medications. Antidepressants do not work at all or only a little in many people with depression and there are new options available.
There are many routes of administration for ketamine. You can get the medication through vein (IV), nose (IN), muscle (IM), mouth, or skin (SQ). There pros and cons to each method. Dr. Banov gives his opinion on what is the best route for you.
If you follow the latest therapies for treatment resistant depression, anxiety, and PTSD, you most certainly have seen the flurry of articles recently about using psilocybin or magic mushrooms. Here's the latest on how to get this miracle therapy!